The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic markers associated with hyperprogression in patients with lung cancer treated with immune checkpoint inhibitors.
 
Eyob ale Tadesse
No Relationships to Disclose
 
Kayla Heslin
No Relationships to Disclose
 
Mohamed Hendawi
No Relationships to Disclose
 
Luke Peterson
Employment - Syapse
Stock and Other Ownership Interests - Syapse
 
Frank M. Wolf
Employment - Syapse
 
Thomas D. Brown
Employment - GenomiCare Biotechnology (I); Syapse
Leadership - Syapse
Stock and Other Ownership Interests - GenomiCare Biotechnology; Syapse; Sygnomics
Honoraria - Novartis
Consulting or Advisory Role - GenomiCare Biotechnology; Jiahui Health; Lug Healthcare Technology; Syapse
Speakers' Bureau - Novartis; Syapse
Travel, Accommodations, Expenses - GenomiCare; Jiahui Health; Lug Healthcare Technology; Novartis; Syapse
 
Michael A. Thompson
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AIM Specialty Health; Celgene; GlaxoSmithKline; GRAIL; Strata Oncology; Syapse; Takeda; VIA Oncology
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); Bristol-Myers Squibb (Inst); Cancer Research and Biostatistics (Inst); Denovo Biopharma (Inst); GlaxoSmithKline (Inst); Lynx Biosciences (Inst); PrECOG (Inst); Strata Oncology (Inst); Takeda (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Travel, Accommodations, Expenses - GlaxoSmithKline; Syapse; Takeda
Other Relationship - Doximity